DTI-guided minimally invasive surgery for deep brain bleeding
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial studies whether a special scan-guided, minimally invasive procedure can safely remove bleeding in the basal ganglia (deep in the brain) soon after it happens. It may help patients recover better by targeting the bleeding while protecting important brain pathways.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 80 years old.
- Have a CT-confirmed brain bleed in the basal ganglia (not other brain areas like the brainstem/thalamus/cerebellum).
- Bleeding volume is about 20–40 mL, and the brain’s middle line is shifted less than 3 mm.
- The bleed started within 24 hours and you can be randomized soon after onset.
- MRI shows the key nerve pathway (corticospinal tract) is partly intact (graded 2 to 4).
- You are medically stable enough for the trial: GCS score 4 or higher, and leg/arm muscle strength in the affected limb is level 3; you (or a legal representative) can consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a rapid procedure to remove a blood clot in the brain after a specific type of stroke. It might help people with a moderate-sized bleed in the front part of the brain if treatment can start within 24 hours.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain after a spontaneous bleed. It may help patients with moderate to large bleeds who are at least 18 and up to 80 years old.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain caused by spontaneous bleeding. It aims to improve recovery for patients who meet specific criteria, such as clot size and time since symptoms started.
This trial tests whether a minimally invasive brain surgery using an endoscope can improve outcomes for people with a deep brain bleed. It also studies the safety of this approach compared with standard care.
This trial tests if a minimally invasive surgery guided by a robotic AI system can help people with moderate bleeding deep inside the brain (basal ganglia). If you qualify, the surgery would happen within 72 hours of your stroke.
This trial studies whether a minimally invasive, image-guided endoscopic procedure can remove blood after a specific type of brain bleed. It may help reduce symptoms and improve outcomes compared with standard care, but you must meet timing and medical criteria.
Hear when a new Hemorrhagic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.